Labiotech.eu

News and Trends 24 Apr 2020

Big €10M Seed Round Funds New Class of Cancer Drugs in Switzerland

The Swiss biotech FoRx Therapeutics has raised an impressive €10M in seed funding to develop a new generation of drugs that target DNA repair in cancer cells. The drugs will block a DNA repair process called break-induced replication, which was discovered by the company’s scientific founder Thanos Halazonetis. This process is used by cancer cells […]

April 24, 2020 - 3 minutesmins - By Laura Cowen

News and Trends 24 Apr 2020

First Volunteers Dosed with European Coronavirus Vaccine

The first European vaccine for coronavirus disease to enter clinical trials has been administered to UK volunteers in a project led by the University of Oxford. One volunteer was injected with the coronavirus vaccine and another with a control vaccine yesterday in a phase I trial that aims to recruit over 1,000 participants. The trial […]

April 24, 2020 - 3 minutesmins - By Jonathan Smith

microfluidics cell therapy gene therapy microfluidX

News and Trends 24 Apr 2020

UK Startup to Manufacture Cell and Gene Therapies with Microfluidics

The UK company MicrofluidX has closed a €1.6M (£1.4 M) seed funding round to develop a microfluidic platform that could produce cell and gene therapies more cheaply than conventional cell cultures. The funding round was led by UKI2S, a national seed investment fund targeting early-stage companies, as well as Longwall Ventures and Cambridge Angels. MicrofluidX […]

April 24, 2020 - 3 minutesmins - By David Kirk

News and Trends 23 Apr 2020

Mogrify Teams Up With Sangamo To Streamline Cell Immunotherapies

The UK cell conversion startup Mogrify and the US genomic medicine company Sangamo have reached an exclusive license agreement that could allow Sangamo to scale up the production of off-the-shelf Treg cell therapies for inflammatory and autoimmune diseases. Under the terms of the agreement, Mogrify will receive an undisclosed upfront payment from Sangamo and will […]

April 23, 2020 - 3 minutesmins - By Laura Cowen

Orchard therapeutics gene therapy header

News and Trends 23 Apr 2020

Sofinnova Invests €20M in Three Italian Rare Disease Biotechs

The French VC firm Sofinnova Partners has invested €20M in three Italian biotech companies via its Telethon Fund, which focuses on firms developing treatments for rare diseases. The deals by the Sofinnova Telethon Fund were made over the last several months. The companies the Fund invested in — Genespire, Epsilen Bio, and PinCell — are […]

April 23, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 22 Apr 2020

€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating

The French startup Phost’in Therapeutics has raised €10.3M to take its cancer immunotherapy drug against solid tumors into clinical trials within a year. Led by the US-Japanese venture capital firm Remiges Ventures, the Series A round also included contributions from Japanese investment firm ANRI and French private equity investor Irdi Soridec Gestion. The cash injection […]

April 22, 2020 - 3 minutesmins - By Anita Chakraverty

News and Trends 21 Apr 2020

Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia

The Swiss pharmaceutical company Idorsia has announced that its drug candidate daridorexant significantly improved sleep onset, sleep quality, and daytime functioning of insomnia patients in a pivotal phase III trial. The trial recruited 930 adult patients with insomnia. The company used a technique called polysomnography to measure the time taken to fall asleep and sleep […]

April 21, 2020 - 3 minutesmins - By Karen O’Hanlon Cohrt

In Depth 20 Apr 2020

How Has Coronavirus Affected Europe’s Biotech Stocks?

The information flow about the coronavirus pandemic is truly electrifying, with big public market swings in the life sciences industry. That said, exactly what sort of impact is the disease known as Covid-19 having on biotech stocks? In the last few months, the Covid-19 pandemic situation has rocked the stock markets, causing intense swings across […]

April 20, 2020 - 12 minutesmins - By Carlos de Rojas

News and Trends 17 Apr 2020

French Biotech Licenses Microbiome Therapeutic to Treat Mood Disorders

The microbiome company LNC Therapeutics has entered into a licensing agreement to use a specific strain of gut bacteria for the treatment of mood disorders such as depression and anxiety. The agreement was made with the National Research Council (CSIC) in Spain, and gives LNC Therapeutics exclusive research, manufacturing, and commercialization rights of the microbiome-based […]

April 17, 2020 - 3 minutesmins - By Laura Cowen

News and Trends 17 Apr 2020

Is New Enzyme Technology Key to Solving Society’s Plastic Problem?

A new type of enzyme developed by the French company Carbios can break down more than 90% of the plastic PET, commonly used to make plastic bottles, and the byproducts can then be recycled into new PET. But how far does this go towards solving our plastic waste problem? PET, or polyethylene terephthalate, comprises around […]

April 17, 2020 - 4 minutesmins - By Helen Albert

Startup Scout 17 Apr 2020

Amphista Therapeutics Is Silencing Disease Proteins to Treat Cancer

Amphista Therapeutics, based in Glasgow, Scotland, is the latest company to develop drugs called PROTACs, which are designed to make the cell degrade harmful proteins to treat cancer. Small molecule drugs have shown incredible potential for the treatment of cancer by blocking harmful proteins in the cell. However, many promising protein targets for cancer treatments […]

April 17, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 16 Apr 2020

Irish Biotech Raises €18M to Develop Non-Viral Cell Therapy Technology

The Irish company Avectas has closed a Series C round to develop cell therapies that don’t need viral vectors — a common bottleneck in cell therapy manufacturing. The fundraise of approximately €18M brings Avectas’ total equity funding to around €37M. The round was led by the company’s current shareholders, which include the serial life sciences […]

April 16, 2020 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Big €10M Seed Round Funds New Class of Cancer Drugs in Switzerland

First Volunteers Dosed with European Coronavirus Vaccine

UK Startup to Manufacture Cell and Gene Therapies with Microfluidics

Mogrify Teams Up With Sangamo To Streamline Cell Immunotherapies

Sofinnova Invests €20M in Three Italian Rare Disease Biotechs

€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating

Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia

How Has Coronavirus Affected Europe’s Biotech Stocks?

French Biotech Licenses Microbiome Therapeutic to Treat Mood Disorders

Is New Enzyme Technology Key to Solving Society’s Plastic Problem?

Amphista Therapeutics Is Silencing Disease Proteins to Treat Cancer

Irish Biotech Raises €18M to Develop Non-Viral Cell Therapy Technology

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!